{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:22:36Z","timestamp":1791638556775,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The prognosis of chronic lymphocytic leukemia (CLL) has been improved dramatically, but there are limited studies focusing on CLL disease burden on a global scale.  We aimed to evaluate the accurate assessment of the disease burden of CLL that may provide more detailed epidemiological information for rational policies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The main source of the data was the Global Burden of Disease (GBD) study 2019. Incident cases, death cases, disability-adjusted life years (DALYs), and their corresponding age-standardized rates (ASRs) from 1990 to 2019 were used to describe the burden of CLL. Data about attributable risk factors were also extracted and analyzed. Bayesian age-period-cohort (BAPC) models were used to assess and project the incidence and mortality rates till 2030.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Globally, the incidence of CLL had been increasing. Deaths and DALYs decreased slightly. The burden of death and DALY is affected by socio-demographic index (SDI). The incidence rate, death rate, and DALY rate of CLL increased significantly with age. Male-to-female ratios of incidence rates varied in different SDI quintiles. Smoking, high body mass index, and occupational exposure to benzene or formaldehyde were the potential risk factors related to CLL. Global ASIRs might tend to increase until 2030, while ASDR would decrease until 2030.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The disease burden of CLL decreased in higher SDI countries but increased in lower ones. Strategies for early detection of asymptomatic CLL, development of novel drugs, and measures against attributable factors should be implemented to combat CLL\u00a0burden.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.840616","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T15:01:01Z","timestamp":1646924461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Yang","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiankui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950101)75:1+<381::AID-CNCR2820751320>3.0.CO;2-B","article-title":"Leukemias, Myeloma, and Other Lymphoreticular Neoplasms","volume":"75","author":"Hern\u00e1ndez","year":"1995","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of Haematological Malignancy by Sub-Type: A Report From the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of Leukemia Incidence in the United States by Subtype and Demographic Characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","journal-title":"Cancer Causes Control CCC"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01057-5","article-title":"Ethnic and Geographic Diversity of Chronic Lymphocytic Leukaemia","volume":"35","author":"Yang","year":"2021","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30232-6","article-title":"Epidemiological Patterns of Leukaemia in 184 Countries: A Population-Based Study","volume":"5","author":"Miranda-Filho","year":"2018","journal-title":"Lancet Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000168","article-title":"Approaches for Relapsed CLL After Chemotherapy-Free Frontline Regimens","volume":"2020","author":"Roeker","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18020701","article-title":"Comorbidities at Diagnosis, Survival, and Cause of Death in Patients With Chronic Lymphocytic Leukemia: A Population-Based Study","volume":"18","author":"Villavicencio","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e14258","DOI":"10.1111\/ijcp.14258","article-title":"Epidemiology, Treatment Patterns and Survival of Chronic Lymphocytic Leukaemia\/Small Lymphocytic Lymphoma (CLL\/SLL) in Taiwan, 2006-2015","volume":"75","author":"Ko","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820910","article-title":"Depth and Durability of Response to Ibrutinib in CLL: 5-Year Follow-Up of a Phase 2 Study","volume":"131","author":"Ahn","year":"2018","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009578","article-title":"Efficacy of Venetoclax Plus Rituximab for Relapsed CLL: 5-Year Follow-Up of Continuous or Limited- Duration Therapy","volume":"138","author":"Ma","year":"2021","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-020-0715-5","article-title":"Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape","volume":"21","author":"Iovino","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"B13","volume-title":"Global Burden of Disease Study 2019 (GBD 2019) Results","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.598215","article-title":"The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China","volume":"8","author":"Li","year":"2020","journal-title":"Front Public Health"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202809","article-title":"Global, Regional, and National Burdens of Leukemia From 1990 to 2017: A Systematic Analysis of the Global Burden of Disease 2017 Study","volume":"13","author":"Lin","year":"2021","journal-title":"Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/cac2.12094","article-title":"Analysis of the Global Burden of Disease Study Highlights the Trends in Death and Disability-Adjusted Life Years of Leukemia From 1990 to 2017","volume":"40","author":"Ou","year":"2020","journal-title":"Cancer Commun (London England)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for Accurate and Transparent Health Estimates Reporting: The GATHER Statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet (London England)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet (London England)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102762","article-title":"Global Burden of Larynx Cancer, 1990-2017: Estimates From the Global Burden of Disease 2017 Study","volume":"12","author":"Deng","year":"2020","journal-title":"Aging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The Trends in Incidence of Primary Liver Cancer Caused by Specific Etiologies: Results From the Global Burden of Disease Study 2016 and Implications for Liver Cancer Prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.203","article-title":"Prediction of Cancer Incidence and Mortality in Korea, 2020","volume":"52","author":"Jung","year":"2020","journal-title":"Cancer Res Treat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1053\/j.gastro.2018.01.033","article-title":"Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030","volume":"154","author":"Wu","year":"2018","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12894-019-0487-z","article-title":"Testicular Cancer Mortality in Brazil: Trends and Predictions Until 2030","volume":"19","author":"Soares","year":"2019","journal-title":"BMC Urol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canep.2019.03.004","article-title":"Future of Cancer Incidence in Shanghai, China: Predicting the Burden Upon the Ageing Population","volume":"60","author":"Liu","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00195-3","article-title":"Trends and Projections of Kidney Cancer Incidence at the Global and National Levels, 1990-2030: A Bayesian Age-Period-Cohort Modeling Study","volume":"8","author":"Du","year":"2020","journal-title":"biomark Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R Package for an Integrated Evaluation of Statistical Approaches to Cancer Incidence Projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the Future Burden of Cancer","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9876.00260","article-title":"Application of Markov Chain Monte Carlo Methods to Projecting Cancer Incidence and Mortality","volume":"51","author":"Bray","year":"2002","journal-title":"J R Stat Soc: Ser C (Appl Statistics)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the Future Burden of Cancer: Bayesian Age-Period-Cohort Analysis With Integrated Nested Laplace Approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fonc.2019.00098","article-title":"Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S153951","article-title":"The Trends and Projections in the Incidence and Mortality of Liver Cancer in Urban Shanghai: A Population-Based Study From 1973 to 2020","volume":"10","author":"Bai","year":"2018","journal-title":"Clin Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.12.001","article-title":"The Mystery of Chronic Lymphocytic Leukemia (CLL): Why is it Absent in Asians and What Does This Tell Us About Etiology, Pathogenesis and Biology","volume":"29","author":"Yang","year":"2015","journal-title":"Blood Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-LB-23","article-title":"Genome-Wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-308205","article-title":"Genome-Wide Association Study Identifies a Novel Susceptibility Locus at 6p21.3 Among Familial CLL","volume":"117","author":"Slager","year":"2011","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-413591","article-title":"Common Variation at 6p21.31 (BAK1) Influences the Risk of Chronic Lymphocytic Leukemia","volume":"120","author":"Slager","year":"2012","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12070","article-title":"Common Variants Within 6p21.31 Locus are Associated With Chronic Lymphocytic Leukaemia and, Potentially, Other non-Hodgkin Lymphoma Subtypes","volume":"159","author":"Slager","year":"2012","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01518.x","article-title":"Genetic Susceptibility for Chronic Lymphocytic Leukemia Among Chinese in Hong Kong","volume":"85","author":"Lan","year":"2010","journal-title":"Eur J Haematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4239-7","article-title":"Clinical Presentation and Hematological Profile Among Young and Old Chronic Lymphocytic Leukemia Patients in Sudan","volume":"12","author":"Basabaeen","year":"2019","journal-title":"BMC Res Notes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.2.793","article-title":"Clinico-Hematological Profile of Patients With B-Chronic Lymphoid Leukemia in Pakistan","volume":"16","author":"Zeeshan","year":"2015","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.672734","article-title":"Assessment of 285 Cases of Chronic Lymphocytic Leukemia Seen at Single Large Tertiary Center in Northern India","volume":"53","author":"Gogia","year":"2012","journal-title":"Leukemia Lymphoma"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical Staging of Chronic Lymphocytic Leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"B44","article-title":"Chronic Lymphocytic Leukaemia: a-Twenty-Years Experience and Problems in Ile-Ife, South-Western Nigeria","volume":"10","author":"Salawu","year":"2010","journal-title":"Afr Health Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A New Prognostic Classification of Chronic Lymphocytic Leukemia Derived From a Multivariate Survival Analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25595","article-title":"Chronic Lymphocytic Leukemia: 2020 Update on Diagnosis, Risk Stratification and Treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am J Hematol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1055-9965.EPI-15-1109","article-title":"The Evolving Scale and Profile of Cancer Worldwide: Much Ado About Everything","volume":"25","author":"Bray","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored by Am Soc Prev Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4949.1172","article-title":"Clinical Trials of P-(Di-2-Chloroethylamino)-Phenylbutyric Acid (CB 1348) in Malignant Lymphoma","volume":"2","author":"Galton","year":"1955","journal-title":"Br Med J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2141.1961.tb00321.x","article-title":"The Use of Chlorambucil and Steroids in the Treatment of Chronic Lymphocytic Leukaemia","volume":"7","author":"Galton","year":"1961","journal-title":"Br J Haematol"},{"key":"B50","first-page":"17","article-title":"TREATMENT OF CHRONIC LYMPHATIC LEUKEMIA WITH A NEW ALKYLATING AGENT, CYCLOPHOSPHAMIDE","volume":"91","author":"Farrerasvalenti","year":"1963","journal-title":"Rev Clin Espanola"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24282","article-title":"Chronic Lymphocytic Leukemia (CLL)-Then and Now","volume":"91","author":"Rai","year":"2016","journal-title":"Am J Hematol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00012","article-title":"Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States","volume":"6","author":"Sathyanarayanan","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/GO.20.00276","article-title":"Chronic Lymphocytic Leukemia: Prognostic Factors at Presentation in a Resource-Limited Center","volume":"7","author":"Korubo","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30814","article-title":"Occupational Solvent Exposure and Adult Chronic Lymphocytic Leukemia: No Risk in a Population-Based Case-Control Study in Four Nordic Countries","volume":"141","author":"Talibov","year":"2017","journal-title":"Int J Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113354","article-title":"Leukemia and Farm Practices in Iowa","volume":"115","author":"Burmeister","year":"1982","journal-title":"Am J Epidemiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.12.012","article-title":"Established and Suggested Exposures on CLL\/SLL Etiology: Results From the CLL-MCC-Spain Study","volume":"52","author":"Benavente","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580759","article-title":"Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017","volume":"10","author":"Lin","year":"2020","journal-title":"Front Oncol"},{"key":"B59","article-title":"Institute for Health Metrics and Evaluation (IHME)","year":"2020"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.840616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T15:01:06Z","timestamp":1646924466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.840616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":58,"alternative-id":["10.3389\/fonc.2022.840616"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.840616","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"840616"}}